Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Maky Zanganeh Insider Profile
39 Followers
Maky Zanganeh, COO at Pharmacyclics, holds 35.74M shares in Summit Therapeutics (Ticker: SMMT), holds 813.23K shares in Pulse Biosciences (Ticker: PLSE), holds 0.00 shares in Pharmacyclics (Ticker: PCYC). Most recently, Maky Zanganeh Bought ― shares of Summit Therapeutics on Oct 03, 2024 for an estimated value of 498.78K.
Profitable Transactions
10 out of 19 Profitable Transactions
Average Return
+102.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Maky Zanganeh holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 13, 2023 - Dec 13, 2024
Return:+661.90%
The most profitable trade made by Maky Zanganeh
Maky Zanganeh's Trading History
Pharmacyclics
May 27, 2015
―
Uninformative Sell
111.89M
―
Pulse Biosciences
Nov 15, 2023
Director
Uninformative Buy
162.80K
$14.62M
Summit Therapeutics
Oct 03, 2024
Co- CEO, Director
Informative Buy
498.78K
$638.65M
List of latest transactions for each holding click on a transaction to see Maky Zanganeh's performance on stock
You May Also Like
Maky Zanganeh insider profile FAQ
What is the percentage of profitable transactions made by Maky Zanganeh?
The percentage of profitable transactions made by Maky Zanganeh is 53%.
What is the average return per transaction made by Maky Zanganeh?
The average return per transaction made by Maky Zanganeh is 102.10%.
What stocks does Maky Zanganeh hold?
Maky Zanganeh holds: PCYC, PLSE, SMMT stocks.
What was Maky Zanganeh’s latest transaction?
Maky Zanganeh latest transaction was an Informative Buy of $498.78K.
What was Maky Zanganeh's most profitable transaction?
Maky Zanganeh’s most profitable transaction was an Informative Buy of SMMT stock on December 13, 2023. The return on the trade was 661.90%.
What is Maky Zanganeh's role in Pharmacyclics?
Maky Zanganeh's role in Pharmacyclics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.